Nicholas A. Livingston, PhD

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Livingston is a PI within the National Center for PTSD, Behavioral Science Division, at VA Boston Healthcare System, and an Associate Professor of Psychiatry at the Chobanian and Avedisian School of Medicine. His research focuses on complementary areas of substance use disorder (SUD) and posttraumatic stress disorder (PTSD) comorbidity, treatment access and outcomes, and predicting and preventing adverse events (e.g., overdose death, suicide). Dr. Livingston also studies the disproportionate risk of suicide, overdose and alcohol-attributable death among vulnerable veteran populations.

He has received funding to support examinations of the impacts of federal policy changes governing medication for opioid use disorder (MOUD) on access to care, treatment retention, and patient outcomes (PCORI LTF-2024C2-39670 & COVID-2020C2-11081; PI: Livingston); the long-term impacts of combat and other traumas among OEF/OIF/OND veterans (W81XWH-22-S-TBIPH2; PIs: Marx & Bovin); and various studies focused on VA health services and patient outcomes. His current research priorities include improving access to patient-centered SUD and PTSD treatment, deriving mortality phenotypes and modeling risk of death among veterans, and leveraging large language modeling and AI to identify novel markers of risk using electronic medical record data.

Dr. Livingston is a mentor on numerous early career development awards (e.g., K, VA CDA-2) and is core training faculty for the Boston University NIMH T32, VA Medical Informatics Fellowship, VA Interprofessional Advanced Fellowship in Addiction Treatment, and other psychology training programs at VA Boston Healthcare System.

Publications

  • Published 7/22/2026

    Collazo EN, Harper KL, Edward D, Simiola V, Ellis AE, Cook JM, Livingston NA. Exploring Minority Stress Outcomes Following Receipt of Motivational Interviewing Among Sexual Minority Men with Histories of Sexual Trauma. Behav Med. 2026 Jul 22; 1-9. PMID: 42482637.

    Read at: PubMed

  • Published 7/1/2026

    Mandavia AD, Coppersmith DDL, Banducci AN, Rose G, Bradley J, Marx BP, Davenport MJ, Livingston NA. The role of PTSD in suicide death and lethal means among veterans with substance use disorders. Psychiatry Res. 2026 Oct; 364:117320. PMID: 42430833.

    Read at: PubMed

  • Published 6/24/2026

    Naganuma-Carreras J, Collazo E, Livingston N, Kearns J, Sager J, Lee D, Keane T, Marx B. Gender differences in criminal justice system involvement and associations with post-deployment factors among Post-9/11 veterans. Health Justice. 2026 Jun 24. PMID: 42340525.

    Read at: PubMed

  • Published 5/27/2026

    Harper KL, Kelton K, Livingston NA, Iverson KM, Sloan CA, Batchelder A, Marx BP. Expressive writing to reduce depressive and anxiety symptoms among sexual minority veterans: Study design for a pilot randomized controlled trial. Contemp Clin Trials Commun. 2026 Jun; 51:101650. PMID: 42255329.

    Read at: PubMed

  • Published 5/4/2026

    Mandavia AD, Coppola EC, Maloney M, Portnoy GA, Presseau C, Iverson KM, Adams RS, Livingston NA. Differences in Intimate Partner Violence Screening, Violence Exposure, and Risk of Lethality Among Veterans with Substance Use Disorders. J Gen Intern Med. 2026 May 04. PMID: 42082854.

    Read at: PubMed

Other Positions

  • Psychologist, National Center for PTSD
    VA Boston Healthcare System

Education

  • University of Montana, PhD
  • University of Montana, MA
  • University of Utah, BS